U.S. Trade Distributors Stock News

NasdaqGS:PRAX
NasdaqGS:PRAXBiotechs

Exploring 3 High Growth Tech Stocks In The US Market

In the last week, the United States market has experienced a 2.2% decline, yet it remains up by 13% over the past year with earnings projected to grow by 17% annually. In this context of fluctuating performance and promising growth forecasts, identifying high growth tech stocks involves looking for companies with strong innovation potential and robust financial health that can capitalize on these favorable conditions.
NasdaqGS:ITRN
NasdaqGS:ITRNCommunications

3 Stocks That May Be Trading Below Their Estimated Value In September 2026

Over the past 7 days, the United States market has experienced a 2.2% decline, though it remains up by 13% over the last year with anticipated earnings growth of 17% per annum in the coming years. In this context, identifying stocks that may be trading below their estimated value can provide investors with opportunities to capitalize on potential future gains while navigating current market fluctuations.
NasdaqGS:NVDA
NasdaqGS:NVDASemiconductor

AI Chips Today - Rackspace Innovates AI Strategy With NVIDIA Partnership

Rackspace Technology has joined the NVIDIA Cloud Partner Program to enhance its ability to deliver NVIDIA accelerated computing solutions for regulated and sovereign enterprises. This collaboration allows Rackspace to advance its AI Cloud strategy by providing the infrastructure and operational models needed for organizations to maintain control over their data and AI environments. Rackspace's new Institutional Sovereign Pod incorporates NVIDIA Blackwell architecture with Palantir software,...
NasdaqGS:CLOV
NasdaqGS:CLOVHealthcare

3 Growth Stocks With Strong Insider Confidence

The market has dropped by 13% in the last 7 days, yet it has risen by 13% over the past year, with earnings forecasted to grow by 17% annually. In this fluctuating environment, identifying growth stocks with high insider ownership can provide insights into companies where those closest to the business have strong confidence in its future potential.
NYSE:OSG
NYSE:OSGInsurance

Myriad Genetics And 2 Other Penny Stocks To Consider

In the last week, the U.S. market has seen a 2.2% decline, yet it has risen by 13% over the past year with expectations of earnings growth by 17% per annum in the coming years. Amidst these market dynamics, identifying good stocks often involves looking beyond traditional metrics to find opportunities in less conventional areas like penny stocks. Although "penny stocks" is an outdated term, it still captures the essence of smaller or emerging companies that can offer significant value when...
NYSE:NJR
NYSE:NJRGas Utilities

Should Dividend Increase Require Action From New Jersey Resources Stock Investors?

New Jersey Resources increased its quarterly dividend to $0.50 per share from $0.475, effective for the payment made on October 1, 2026, with shareowners of record as of September 24, 2026 receiving the higher payout. The new $2.00 per share annual dividend marked the 31st consecutive year of dividend growth, underscoring management’s emphasis on returning cash to investors alongside its regulated utility and clean energy investments. This article examines how New Jersey Resources'...
NYSE:GME
NYSE:GMESpecialty Retail

GameStop (GME) Stock Trades Below Fair Value Despite Mixed Signals

GameStop stock has delivered a steep 5 year decline of about 60%, yet current valuation checks flag a mixed picture rather than a simple verdict of cheap or expensive. The roughly 60% fall over five years means long term holders have seen significant value erode. This makes any hint of undervaluation feel tempting but also raises questions about how durable the underlying business model looks to the market. Stronger profitability tied to its large investment portfolio and tighter cost base...
NYSE:KR
NYSE:KRConsumer Retailing

What Is Kroger (KR) Signaling With Its New Store Operations Chief?

Kroger (NYSE:KR) appointed Mark Ibbotson as Executive Vice President and Chief Store Operations Officer. Ibbotson previously led large scale store and omnichannel operations at Walmart and UK grocer Asda. His remit at Kroger covers store operations, grocery eCommerce and broader omnichannel transformation across the chain. Ibbotson's arrival in Kroger's top ranks is only one piece of how leadership shifts could reshape its store and eCommerce plans. Take a look at 4 warning signs we have...
NYSE:CACI
NYSE:CACIProfessional Services

How Earnings Beat Will Impact CACI International (CACI) Investors

CACI International reported quarterly revenue of $2.71b, up 17.6% year on year, with EBITDA and full-year EPS guidance both ahead of analyst estimates. The combination of rapid top-line expansion and stronger than expected profitability suggests CACI’s higher value technology contracts are scaling effectively across its federal customer base. We will now explore how CACI International’s strong revenue growth and upgraded EPS outlook could influence the longer term investment narrative. Scan...
NYSE:GLW
NYSE:GLWElectronic

Corning (GLW) Stock Could Be 20% Undervalued As Fiber Deal Raises The Stakes

Corning stock has delivered an extremely strong three year gain while the valuation checks send mixed messages, with the Discounted Cash Flow (DCF) pointing to a discount and market multiples suggesting the shares are not cheap. The result is a split picture on where intrinsic value sits after such a steep move. Corning has produced a roughly 4.5x total return over three years, which puts extra weight on whether recent pricing already bakes in much of the good news. The long term fiber...
NasdaqGS:SNDX
NasdaqGS:SNDXBiotechs

Syndax Pharmaceuticals (SNDX) Stock May Be Pricey Following A 15% Gain

Syndax Pharmaceuticals stock has delivered a 15.0% gain over the past year, yet current valuation checks suggest the shares lean expensive on traditional market multiples and only offer a mixed picture on value overall. For anyone tracking biopharma reratings, the key issue is whether that performance still leaves enough room for a return that fairly compensates for the clinical and funding risks ahead. Over the last 12 months, Syndax Pharmaceuticals has gained 15.0%, which puts recent...
NYSE:CCL
NYSE:CCLHospitality

Carnival (CCL) Opens 2028 Bookings For Family Focused Carnival Tropicale From Galveston

Carnival (NYSE:CCL) has opened bookings for its newest Excel class ship, Carnival Tropicale, which is scheduled to sail from Galveston in 2028. The cruise line is promoting newly designed family-focused attractions on Carnival Tropicale, aimed at multigenerational travelers and group trips. Carnival Tropicale itineraries are billed as exclusive routes, giving early bookers access to sailings that were not previously available from Galveston. The early booking launch for Carnival Tropicale...
NYSE:ANET
NYSE:ANETCommunications

Arista Networks (ANET) Gains Campus Switch Share Despite Supply Constraints

Arista Networks (NYSE: ANET) gained campus switch revenue share in the latest Dell'Oro Group report despite industry supply constraints. The research firm cited switch refresh cycles, public cloud demand and security-focused deployments as key drivers for campus switch spending. Vendors, including Arista, lifted average selling prices for campus switches while working through ongoing component shortages and extended lead times. Arista's campus switch share gains, along with higher pricing...
NYSE:AJG
NYSE:AJGInsurance

Arthur J. Gallagher (AJG) Appoints Steve Munday To Lead Natural Resources Push

Arthur J. Gallagher (NYSE:AJG) has hired Steve Munday as managing partner of Natural Resources, focusing on renewables and energy transition. Munday previously led the global renewable practice at WTW and brings decades of sector experience to Gallagher. The move signals Gallagher's push to deepen its capabilities in renewables, clean energy and project finance-focused risk solutions. Steve Munday's appointment to lead Natural Resources is a meaningful move that investors should weigh...
NasdaqCM:SLS
NasdaqCM:SLSBiotechs

How Investors May Respond To SELLAS Life Sciences Group (SLS) Phase 3 Trial Nears

Manulife’s principal operating insurer increased its institutional position in SELLAS Life Sciences during the second quarter, while SELLAS reported that its Phase 3 Regal trial had reached 78 of the 80 events needed for final analysis. This combination of a larger stake from a major insurer and an approaching Phase 3 data readout highlights how SELLAS Life Sciences is moving through a capital intensive phase in which clinical outcomes and funding access closely intersect. We will look at...
NasdaqGS:PENG
NasdaqGS:PENGSemiconductor

Penguin Solutions (PENG) Stock Looks Fairly Valued As Its 140% Run Continues

Penguin Solutions has surged year to date, yet its current checks point to a stock that looks roughly in line with an intrinsic value estimate while earnings multiples still hint at a discount. The share price has climbed 139.7% year to date, which puts extra focus on whether the recent rerating has already absorbed much of the upside. Fresh attention around its role in Lektra's distributed AI data centers can support longer term cash flow expectations, while any slowdown in AI...
NasdaqGS:MGEE
NasdaqGS:MGEEElectric Utilities

Learn Why The Bull Case For MGE Energy (MGEE) Could Change Following Fusion Plant Partnership

Realta Fusion Inc. previously announced a partnership with Madison Gas and Electric and parent MGE Energy to explore a 200-megawatt fusion power plant in Wisconsin, alongside an equity stake and broad technical, siting, and financing support from the utility group. The agreement ties MGE Energy directly into Realta’s fusion research hub at OM Station, linking potential future generation capacity with activity already inside MGE’s service territory. This analysis examines how MGE Energy’s...
NYSE:VST
NYSE:VSTRenewable Energy

Vistra (VST) Files A Shelf Registration, Is The Stock Below Fair Value?

Vistra (VST) has filed an omnibus shelf registration for common and preferred stock, giving the utility additional flexibility to raise equity capital as it weighs funding options amid its current share price slide. Recent trading tells a mixed story for Vistra. The share price is down 2.68% on the day at US$147.05 and has declined 11.00% year to date, while the 1-year total shareholder return has fallen 27.56% after a very large 5-year total shareholder return of roughly 8x. In the short...